구연산칼륨 시장 보고서 : 유형, 용도, 최종사용자, 지역별(2026-2034년)

The global potassium citrate market size reached USD 804.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,079.4 Million by 2034, exhibiting a growth rate (CAGR) of 3.23% during 2026-2034. The growing use in the food and beverages (F&B) sector for improving flavor, stability, and shelf life, rising demand in the pharmaceutical industry for treating kidney stones and urinary tract infections, and increasing popularity of processed and convenience food among busy individuals are some of the factors impelling the market growth.

POTASSIUM CITRATE MARKET ANALYSIS:

• Major Market Drivers: The market is experiencing a steady growth because of the rising use of potassium citrate in the pharmaceutical industry, particularly in treatments for kidney stones and urinary tract infections (UTI).
• Key Market Trends: There is a shift towards the use of potassium citrate in the production of low-sodium food products, catering to the health-conscious population. Moreover, innovations in the production of functional foods and dietary supplements that include potassium citrate are also becoming prevalent.
• Geographical Trends: Asia Pacific dominates the market because of the growing demand for potassium citrate in the food and pharmaceutical sectors.
• Competitive Landscape: Some of the major market players in the potassium citrate industry include Archer-Daniels-Midland Company, ATPGroup, Cargill Incorporated, Dr. Paul Lohmann GmbH & Co. KGaA, FBC Industries, Foodchem International Corporation, Gadot Biochemical Industries Ltd., Huangshi Xinghua Biochemical Co. Ltd., Jiangsu Mupro IFT Corp., Jungbunzlauer Suisse AG, Niran BioChemical Limited, RZBC Group Co. Ltd. and Tate & Lyle PLC., among many others.
• Challenges and Opportunities: The fluctuating raw material prices, which can impact production costs and pricing strategies, are influencing the potassium citrate market revenue. Nonetheless, the industry offers potential for growth, especially in emerging nations where processed foods and health supplements are becoming more popular.

POTASSIUM CITRATE MARKET TRENDS:

Rising Demand for Processed Foods

Potassium citrate is commonly utilized in the processed food sector for improving taste, enhancing consistency, and prolonging the shelf life. The increasing urbanization and people leading busier lives are driving the need for convenient, ready-to-eat (RTE) foods. The size of the worldwide market for ready-to-eat (RTE) food hit US$ 181.5 Billion in 2023. In the future, IMARC Group predicts that the market will achieve a value of US$ 262.4 Billion by 2032, showing a 4.18% growth rate (CAGR) between 2024 and 2032. This increase is resulting in higher utilization of food additives like potassium citrate to uphold the standard and steadiness of processed foods. Moreover, people are becoming aware about their health and are looking for products that have reduced sodium levels. Potassium citrate is a perfect alternative to sodium additives, assisting manufacturers in satisfying the need for healthier food choices. The rising demand for processed food, influenced by evolving consumer tastes and advancements in food processing technologies, is supporting the potassium citrate market growth.

Demand in the Pharmaceutical Sector

The growing use of potassium citrate in the pharmaceutical industry, because of its widespread usage in different medical products, is offering a favorable market outlook. Potassium citrate is greatly appreciated for its role as a potent alkalizing agent in the treatment of kidney stones and urinary tract infections (UTIs). Its ability to balance out extra acids in the urine makes it a favored option for treating conditions such as metabolic acidosis. The rising occurrence of chronic kidney diseases and urinary disorders among the masses is driving the need for medications containing potassium citrate. Moreover, the compound is also used in effervescent tablets and powders to improve their effectiveness and stability. The increasing emphasis on enhancing patient health results and the growing funding in healthcare facilities play a vital role in the demand for potassium citrate in the pharmaceutical field. In 2023, the pharmaceutical market in India was valued at US$ 54.6 billion. The IMARC Group projects that the market will expand at a compound annual growth rate (CAGR) of 12.3% from 2024 to 2032, reaching US$ 163.1 billion in 2032. Potassium citrate market recent developments include breakthroughs in drug formulations and innovative delivery methods that improve the efficacy and stability of potassium citrate-based treatments, further driving the demand in this sector.

Growing Health Awareness and Dietary Supplements Demand

The increasing understanding about the advantages of maintaining a healthy mineral balance and avoiding kidney stones is leading to a rise in the popularity of dietary supplements with potassium citrate. This substance is well known for its capacity to promote kidney well-being by averting the creation of kidney stones and helping in the control of urinary infections. The increasing occurrence of lifestyle-related diseases like high blood pressure and weight gain is catalyzing the demand for supplements that can assist in controlling these conditions. In 2023, the World Health Organization (WHO) published its first report on the global effects of elevated blood pressure. Approximately 80% of individuals with hypertension do not receive sufficient treatment, according to the report. However, if countries can expand coverage, roughly 76 million deaths could be prevented from 2023 to 2050.

POTASSIUM CITRATE MARKET SEGMENTATION:

Breakup by Type:

• Monohydrate
• Anhydrous

Monohydrate is characterized by its widespread use in the pharmaceutical and food and beverage (F&B) industries. Monohydrate potassium citrate is greatly appreciated in the pharmaceutical industry for its efficacy as an alkalizing agent, especially in the management of kidney stones and UTI among the elderly. According to the October 2023 report presented by the UK Health Security Agency (UKHSA) and National Health Service (NHS) of England, 56% (82,392) of the 147,285 admissions for UTI in the 2022/23 period were individuals aged 65 and older. The 80-84 age group had the most admissions at 17,280. The F&B industry gains advantages from it as a buffering and sequestrant agent, maintaining product stability and quality. The increasing recognition of health and wellness by consumers is leading to a strong demand for dietary supplements with monohydrate potassium citrate.

Anhydrous, valued for its exceptional purity and reliability, is widely used in industries that demand strict quality requirements. The pharmaceutical sector uses anhydrous potassium citrate in formulations for products that are sensitive to moisture, guaranteeing extended shelf life and effectiveness. Its function as a buffering agent in the food industry is crucial for ensuring the pH balance of beverages and other products. The dehydrated version is especially preferred for making effervescent tablets and powders because the absence of water is critical to the efficacy of the product.

Breakup by Function:

• Acidulant
• Emulsifier
• Stabilizer
• Antioxidants
• Others

Emulsifier exhibits a clear dominance in the market

Emulsifier holds the largest portion of market, as it plays a vital role in preserving the texture and stability of different food and beverage items. Potassium citrate is commonly utilized as an emulsifier in dairy products and processed foods to maintain a consistent blend and avoid ingredient separation. In 2023, the worldwide dairy market was valued at US$ 944.7 Billion, with forecasts from the IMARC Group suggesting it will grow to US$ 1,459.3 Billion by 2032. The increasing desire for convenient food products and ready to eat meals is catalyzing the demand for efficient emulsifiers, leading to higher potassium citrate demand in this role. Furthermore, the growing desire for clean-label and natural food additives is driving the need for potassium citrate as a favored emulsifier because of its safe and versatile properties. It is anticipated that the segment will maintain its leadership position due to continuous innovations and the increasing use of potassium citrate in both new and existing food items.

Breakup by End User:

• Food and Beverages
• Pharmaceuticals
• Personal Care
• Others

Food and beverages are the predominant market segment

Food and beverages are the largest segment according to the potassium citrate market outlook due to its increasing use as an additive to improve flavor, stability, and shelf life. Potassium citrate is frequently utilized as a buffering agent, acidulant, and emulsifier in various products, such as dairy items, beverages, processed foods, and bakery goods. Its role in controlling level of acidity and enhancing texture is essential in upholding the quality and uniformity of the product. The growing number of consumers favoring low-sodium and healthier food choices is catalyzing the demand for potassium citrate, as it aids in achieving desired flavors without sacrificing health advantages. The increasing popularity of convenient foods and continuous advancements in food processing technologies are also contributing to the growth of the sector, guaranteeing that potassium citrate continues to be a crucial component in the F&B industry.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Asia Pacific leads the market, accounting for the largest potassium citrate market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest regional market for potassium citrate.

The Asia Pacific region is the largest segment in the market, driven by rapid industrialization, urbanization, and growing consumer awareness regarding health and wellness. According to the China in Numbers (2023) report by the United Nations Development Programme (UNDP), the percentage of individuals permanently residing in urban areas has more than tripled since 1982, reaching 66.2% in 2023. The increasing need for potassium citrate in this region is because of the expanding F&B industry and the growing pharmaceutical sector. The rising health-consciousness among consumers in Asia Pacific is resulting in a greater intake of dietary supplements and functional foods which frequently include potassium citrate. Furthermore, the robust agricultural foundation aids in providing a constant source of raw materials for the production of potassium citrate.

COMPETITIVE LANDSCAPE:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the market include Archer-Daniels-Midland Company, ATPGroup, Cargill Incorporated, Dr. Paul Lohmann GmbH & Co. KGaA, FBC Industries, Foodchem International Corporation, Gadot Biochemical Industries Ltd., Huangshi Xinghua Biochemical Co. Ltd., Jiangsu Mupro IFT Corp., Jungbunzlauer Suisse AG, Niran BioChemical Limited, RZBC Group Co. Ltd. and Tate & Lyle PLC. ()
• Major potassium citrate companies are focusing on strategic efforts to enhance their market standing. They are actively engaging in product launches, strategic expansions, and regulatory approvals to strengthen their positions. For instance, Advicenne launched Sibnayal(R) (potassium citrate/potassium bicarbonate) in Denmark in March 2023. The Danish authorities approved its reimbursement, recognizing its therapeutic value for rare renal diseases. These companies are also increasing their manufacturing capabilities and improving their supply chain systems in order to satisfy the increasing need worldwide. Furthermore, key players are forming strategic alliances and making acquisitions in order to expand their range of products and reach in the market. They are implementing environment-friendly manufacturing processes and sourcing methods in line with the growing user demand for natural and sustainable ingredients.

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Potassium Citrate Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Monohydrate
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Anhydrous
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Function

• 7.1 Acidulant
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Emulsifier
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Stabilizer
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Antioxidants
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by End User

• 8.1 Food and Beverages
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Pharmaceuticals
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Personal Care
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Archer-Daniels-Midland Company
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 ATPGroup
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Cargill Incorporated
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 SWOT Analysis
  • 14.3.4 Dr. Paul Lohmann GmbH & Co. KGaA
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 FBC Industries
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Foodchem International Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Gadot Biochemical Industries Ltd.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Huangshi Xinghua Biochemical Co. Ltd.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Jiangsu Mupro IFT Corp.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Jungbunzlauer Suisse AG
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Niran BioChemical Limited
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 RZBC Group Co. Ltd.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
  • 14.3.13 Tate & Lyle PLC
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis